During the past decade, LMG Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LMG Research" #1 sponsor was "Celgene" with 3 trials, followed by "BioVie Inc." with 1 trials sponsored, "PTC Therapeutics" with 1 trials sponsored, "Paradigm Biopharmaceuticals USA (INC)" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "LMG Research" are "Crohn Disease" (3 trials), "Alzheimer Disease" (1 trials), "Gastroparesis" (1 trials), "Influenza, Human" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "LMG Research" in a lesser frequency.

Most popular intervention types in "LMG Research" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "CNSA-001" (1 trials), "NE3107" (1 trials) and "Pentosan Polysulfate Sodium Fixed Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "LMG Research" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "LMG Research". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LMG Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LMG Research, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".